LOTRAFILCON A
UNII R9Y7LX2EQT

Substance Identification & Data

This profile provides standardized clinical and technical data for Lotrafilcon A, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R9Y7LX2EQT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 203179-33-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

R9Y7LX2EQT

CAS Registry Number

203179-33-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LOTRAFILCON A

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199067

National Cancer Institute reference terminology for clinical and research data.

USAN ID

II-68

Identifier assigned by the United States Adopted Names Council.

Substance Type

polymer

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lotrafilcon A. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LOTRAFILCON A

Common Names & Synonyms

2-PROPENOIC ACID, 2-METHYL-, 2-ISOCYANATOETHYL ESTER, POLYMER WITH N,N-DIMETHYL-2-PROPENAMIDE, FOMBLIN Z-DOL, .ALPHA.-((3-(2-HYDROXYETHOXY)PROPYL)DIMETHYLSILYL)-.OMEGA.-(((3-(2-HYDROXYETHOXY)PROPYL)DIMETHYLSILYL)OXY)POLY(OXY(DIMETHYLSILYLENE)), 5-ISOCYANATO-1-(ISOCYANATOMETHYL)-1,3,3-TRIMETHYLCYCLOHEXANE AND 3-(3,3,3-TRIMETHYL-1,1-BIS((TRIMETHYLSILYL)OXY)-1-DISILOXANYL)PROPYL 2-METHYL-2-PROPENOATE (WATER CONTENT 24% AT 23C, OXYGEN PERMEABILITY 140 X 10-11 (CM2 /SEC)(ML O2 /ML X MM HG))

LOTRAFILCON A [USAN]

Brand / Trade Names

SEE3

Systematic Nomenclature

2-ISOCYANATOETHYL METHACRYLATE POLYMER WITH N,N-DIMETHYLACRYLAMIDE, 2,2, 4,4,6,6,8,8,10,10,12,12,14,14,16,16,17,17,19,19,20,20, 22,22,23,23,25,25, 26,26,28,28,29,29,31,31-HEXATRIACONTAFLUORO-3,5,7,9,11,13,15,18,21,24,27,30-DODECAOXADOTRIACONTANE-1,32-DIOL, 2,2-((TETRAPENTACONTAMETHYLHEPTACOSASILOXANYLENE) BIS(TRIMETHYLENEOXY)DIETHANOL, 5-ISOCYANATO-1-(ISOCYANATOMETHYL)-1,3,3-TRIMETHYLCYCLOHEXANE, AND 3-(3,3,3-TRIMETHYL-1,1-BIS(TRIMETHYLSILOXY)DISILOXANYL) PROPYLMETHACRYLATE (WATER CONTENT 24% AT 23C, OXYGEN PERMEABILITY 140 X 10-11 (CM2 /SEC)(ML O2 /ML X MM HG))

SYS

2-PROPENOIC ACID, 2-METHYL-, 2-ISOCYANATOETHYL ESTER, POLYMER WITH N,NDIMETHYL-2-PROPENAMIDE,FOMBLIN Z-DOL,.ALPHA.-((3-(2-HYDROXYETHYL)PROPYL) DIMETHYLSILYL)-.OMEGA.- (((3-(2-HYDROXYETHOXY)PROPYL)DIMETHYLSILYL)OXY)POLY(OXY (DIMETHYLSILYLENE)), 5-ISOCYANATO-1-(ISOCYANATOMETHYL)-1,3,3- TRIMETHYLCYCLOHEXANE, AND 3-(3,3,3-TRIMETHYL-1,1-BIS(TRIMETHYLSILYL)OXY)DISILOXANYL)PROPYL 2-METHYL-2-PROPENOATE (WATER CONTENT 24% AT 23C, OXYGEN PERMEABILITY 140 X 10-11 (CM2 /SEC)(ML O2 /ML X MM HG))

SYS

External Clinical & Regulatory Resources

Previous UNIIR9Y5R8LRV9

Next UNIIR9Y8EY0G42